According to the latest report published by Credence Research, Inc. “Intragastric Balloons Market By Application (Single Balloons, Double Balloons, Triple Balloons, Others), By Usage Area (Hospitals, Ambulatory Centers, Private Clinics) - Growth, Future Prospects and Competitive Analysis, 2017-2025,” The worldwide intragastric balloon market was valued at US$ 120 million in 2015 and is anticipated to achieve US$ 248 million by 2025, increasing to CAGR by 7.6 per cent from 2017 to 2025.

Market Insights                                                  

Intragastric balloons are instruments made of biocompatible silicon and are put inside the stomach to reduce the ability.  Compressed balloons are put in the stomach through a non-invasive endoscopic operation that is filled with saline, which means that the person feels fuller and fuller earlier and longer and makes less space for food. These balloons may be removed once they are no longer required due to the risk of rupture after 6 to 7 months.

Browse the full report at https://www.credenceresearch.com/report/intragastric-balloons-market

According to OECD information in 2015, 19.5% of the adult population was obese. For adolescents, the WHO specifies that obesity is a body mass index (BMI) higher than or equal to 30 and that the majority of this population is from emerging countries. This phenomenon can increase the demand for obesity treatment. With advancements in technology and the accessibility of better medicines for obesity and a rapid rise in obese and overweight populations, the demand for safer and temporary therapy alternatives such as non-invasive endoscopic intragastric balloon therapy is set to raise. The upward trend in the growth rate of the overweight and obese population in adolescents and kids has shown a strong impact on the market. In addition, advancements in technology and regulatory aspects of the industry are further improving the market for intragastric balloons. In 2011-2014, according to CDC information, the incidence of obesity was 36% among U.S. adults and 17% among youth. Growing rates of obesity among adolescents and young people are one of the primary factors driving market growth.

On the basis of application fields, the worldwide market for intragastric balloons is divided into single balloons, double balloons and triple balloons. Advancing technology and increasing incidence of adult obesity, improved awareness of patience and increased disposable income in emerging countries would further boost the adoption of intragastric balloons.

Geographically, the global intragastric balloons market is studied for North America, Europe, Asia Pacific, Latin America and Middle East and Africa. North America currently leads the global market in terms of revenue share and it is expected that the region will retain its dominance during the forecast period. However, the dominance of North America will be prominently challenged by Europe and Asia Pacific market. The demand for advanced treatment for obesity has exponentially increased in Asia Pacific due to growth in healthcare expenditure, disposable income and rapid proliferation of healthcare infrastructure. Furthermore, countries such as Brazil, Mexico, China, and India will open additional opportunities for market penetration to key companies already having a stronghold in developed regions.

Download Free PDF Sample Request: https://www.credenceresearch.com/sample-request/58845

By Application Type

Single Balloons
Double Balloons
Triple Balloons
Others
By Usage Area

Hospitals
Ambulatory Centers
Private Clinics
By Geography Segment

North America
Europe
Asia Pacific (APAC)
Middle East & Africa (MEA)
Latin America
Medium Blog: https://medium.com/@kumarganesh028/intragastric-balloons-market-size-share-growth-trends-analysis-and-forecast-2017-to-2025-8dd5fd0cabc1